Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

A repair pathway lost in multiple sclerosis provides a new drug opportunity.

Jensen LT. et al, (2024), Nat Immunol, 25, 385 - 386

Ancient DNA reveals evolutionary origins of autoimmune diseases.

Barrie W. et al, (2024), Nat Rev Immunol

Elevated genetic risk for multiple sclerosis emerged in steppe pastoralist populations.

Barrie W. et al, (2024), Nature, 625, 321 - 328

The selection landscape and genetic legacy of ancient Eurasians.

Irving-Pease EK. et al, (2024), Nature, 625, 312 - 320

Allosteric TYK2 inhibition: redefining autoimmune disease therapy beyond JAK1-3 inhibitors.

Jensen LT. et al, (2023), EBioMedicine, 97

Mouse fetal growth restriction through parental and fetal immune gene variation and intercellular communications cascade.

Kaur G. et al, (2022), Nat Commun, 13

Identification of early neurodegenerative pathways in progressive multiple sclerosis.

Kaufmann M. et al, (2022), Nat Neurosci

The immunology of multiple sclerosis.

Attfield KE. et al, (2022), Nat Rev Immunol

MOG antibody-associated disease after vaccination with ChAdOx1 nCoV-19.

Francis A. et al, (2022), Lancet Neurol, 21, 217 - 218

Inflammation-related plasma and CSF biomarkers for multiple sclerosis.

Huang J. et al, (2020), Proc Natl Acad Sci U S A

A novel neurodegenerative spectrum disorder in patients with MLKL deficiency.

Faergeman SL. et al, (2020), Cell Death Dis, 11

Identifying cross-disease components of genetic risk across hospital data in the UK Biobank.

Cortes A. et al, (2019), Nat Genet

A plasmid-encoded peptide from Staphylococcus aureus induces anti-myeloperoxidase nephritogenic autoimmunity.

Ooi JD. et al, (2019), Nat Commun, 10

HLA variation and disease.

Dendrou CA. et al, (2018), Nat Rev Immunol, 18, 325 - 339

The Human Cell Atlas.

Regev A. et al, (2017), Elife, 6

Immunomodulation in multiple sclerosis: promises and pitfalls.

Dendrou CA. and Fugger L., (2017), Curr Opin Immunol, 49, 37 - 43

Bayesian analysis of genetic association across tree-structured routine healthcare data in the UK Biobank.

Cortes A. et al, (2017), Nat Genet, 49, 1311 - 1318

DOMINANT HLA-MEDIATED PROTECTION FROM THE RISK OF AUTOIMMUNE RENAL DISEASE IS CONFERRED BY ANTIGEN-SPECIFIC REGULATORY T CELLS

Ooi JD. et al, (2017), NEPHROLOGY, 22, 16 - 16

Structural and regulatory diversity shape HLA-C protein expression levels.

Kaur G. et al, (2017), Nat Commun, 8

Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells.

Ooi JD. et al, (2017), Nature, 545, 243 - 247

Load More

1
2
3
4
5

Include forthcoming?